Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMothercare Regulatory News (MTC)

Share Price Information for Mothercare (MTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.35
Bid: 6.20
Ask: 6.50
Change: 0.00 (0.00%)
Spread: 0.30 (4.839%)
Open: 6.35
High: 0.00
Low: 0.00
Prev. Close: 6.35
MTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Mothercare plc

3 Jul 2014 10:58

ABERFORTH PARTNERS LLP - Form 8.3 - Mothercare plc

ABERFORTH PARTNERS LLP - Form 8.3 - Mothercare plc

PR Newswire

London, July 3

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Identity of the person whose positions/ Aberforth Partners LLP, ondealings are being disclosed: behalf of discretionary clients. (b) Owner or controller of interests and shortpositions disclosed, if different from 1(a): The naming of nominee or vehicle companies isinsufficient (c) Name of offeror/offeree in relation to Mothercare plcwhose relevant securities this form relates: Use a separate form for each offeror/offeree (d) If an exempt fund manager connected withan offeror/offeree, state this and specifyidentity of offeror/offeree: (e) Date position held/dealing undertaken: 02 July 2014 (f) Has the discloser previously disclosed, or Y/N NOare they today disclosing, under the Code inrespect of any other party to this offer? If YES, specify which: 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE (a) Interests and short positions in the relevant securities of the offeror orofferee to which the disclosure relates following the dealing (if any) Class of relevant security: Ordinary Shares Interests Short positions Number % Number % (1) Relevant securities owned 6,295,193 7.09 0 0.0and/or controlled: (2) Derivatives (other thanoptions): (3) Options and agreements topurchase/sell: TOTAL: 6,295,193 7.09 0 0.0 Aberforth Partners LLP does not have discretion regarding voting decisions inrespect of 1,330,168 shares included in the total disclosed above. All interests and all short positions should be disclosed. Details of any open derivative or option positions, or agreements to purchaseor sell relevant securities, should be given on a Supplemental Form 8 (OpenPositions). (b) Rights to subscribe for new securities (including directors' and otherexecutive options) Class of relevant security in N/Arelation to which subscription rightexists: Details, including nature of the N/Arights concerned and relevantpercentages: If there are positions or rights to subscribe to disclose in more than oneclass of relevant securities of the offeror or offeree named in 1(c), copytable 2(a) or (b) (as appropriate) for each additional class of relevantsecurity. 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (a) Purchases and sales Class of relevant Purchase/sale Number of Price per unit security securities N/A- Opening Disclosure (b) Derivatives transactions (other than options) Class of Product Nature of dealing Number of Price per relevant description reference unit security e.g. opening/closing a securities e.g. CFD long/short position, increasing/reducing a long/short position N/A (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Class of Product Writing, Number of Exercise Type Expiry Optionrelevant description purchasing, securities price date moneysecurity e.g. call selling, to which per unit e.g. paid/ option varying option American, received etc. relates European per unit etc. N/A (ii) Exercising Class of relevant Product Number of Exercise price per security description securities unit e.g. call option N/A (d) Other dealings (including subscribing for new securities) Class of relevant Nature of dealing Details Price per unit security (if applicable) e.g. subscription, conversion N/A The currency of all prices and other monetary amounts should be stated. Where there have been dealings in more than one class of relevant securities ofthe offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (asappropriate) for each additional class of relevant security dealt in. 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement orunderstanding, formal or informal, relating to relevant securities which maybe an inducement to deal or refrain from dealing entered into by the personmaking the disclosure and any party to the offer or any person acting inconcert with a party to the offer: If there are no such agreements, arrangements or understandings, state "none" None (b) Agreements, arrangements or understandings relating to options orderivatives Details of any agreement, arrangement or understanding, formal or informal,between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevantsecurities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" None (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 03 July 2014 Contact name: David Holland, for Aberforth Partners LLP Telephone number: 0131 220 0733 Public disclosures under Rule 8 of the Code must be made to a RegulatoryInformation Service and must also be emailed to the Takeover Panel atmonitoring@disclosure.org.uk . The Panel's Market Surveillance Unit isavailable for consultation in relation to the Code's dealing disclosurerequirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

3

Date   Source Headline
3rd Aug 20214:35 pmRNSPrice Monitoring Extension
29th Jul 20217:00 amRNSFinal Results
5th Jul 20217:15 amGNWHolding(s) in Company
9th Jun 20214:41 pmRNSSecond Price Monitoring Extn
9th Jun 20214:36 pmRNSPrice Monitoring Extension
25th May 20217:00 amGNWPre-close Trading and Business Update
10th May 20219:00 amGNWStatement re timing of FY21 pre-close trading update
1st Apr 20213:57 pmGNWTotal voting rights
25th Mar 20214:41 pmRNSSecond Price Monitoring Extn
25th Mar 20214:35 pmRNSPrice Monitoring Extension
18th Mar 20214:04 pmGNWHolding(s) in Company
18th Mar 20213:59 pmGNWHolding(s) in Company
18th Mar 20212:34 pmGNWHolding(s) in Company
18th Mar 20212:07 pmGNWHolding(s) in Company
18th Mar 20212:04 pmGNWHolding(s) in Company
16th Mar 20211:30 pmGNWCompletion of the CULS Arrangements and Related Party Transactions
12th Mar 20217:00 amGNWAdmission to AIM
11th Mar 20212:51 pmGNWBlock listing application
5th Mar 20216:00 pmRNSMothercare
19th Feb 20214:41 pmRNSSecond Price Monitoring Extn
19th Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20218:00 amRNSAppendix to Schedule One Announcement
11th Feb 20218:00 amRNSSchedule One - Mothercare PLC
10th Feb 202112:45 pmRNSResult of General Meeting
8th Feb 20215:15 pmRNSHolding(s) in Company
27th Jan 20211:41 pmRNSHolding(s) in Company
25th Jan 20217:00 amRNSDelisting and Notice of General Meeting
15th Jan 20214:47 pmRNSHolding(s) in Company
23rd Dec 202012:00 pmRNSDirector/PDMR Shareholding
21st Dec 20207:00 amRNSBlock listing Interim Review
26th Nov 20201:15 pmRNSGeneral Meeting Results
26th Nov 20208:30 amRNSHalf Year Results
28th Oct 20207:15 amRNSNotice of General Meeting
1st Oct 20207:00 amRNSDirector/PDMR Shareholdings
25th Sep 202010:30 amRNSANNUAL REPORT AND FINANCIAL STATEMENTS
25th Sep 20207:00 amRNSFinal Results
23rd Sep 20203:30 pmRNSResult of AGM
24th Aug 202011:58 amGNWNotice of AGM
20th Aug 20207:00 amGNWFurther re Transformation Plan Update
5th Aug 20204:40 pmRNSSecond Price Monitoring Extn
5th Aug 20204:36 pmRNSPrice Monitoring Extension
27th Jul 20204:40 pmRNSSecond Price Monitoring Extn
27th Jul 20204:35 pmRNSPrice Monitoring Extension
24th Jul 202010:23 amGNWDirectorate change
7th Jul 20204:35 pmRNSPrice Monitoring Extension
6th Jul 20204:41 pmRNSSecond Price Monitoring Extn
6th Jul 20204:36 pmRNSPrice Monitoring Extension
2nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
29th Jun 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.